Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Heilig

Showing results (291-300 of 313) with videos related to

Pageof 32
Sort By:
Molecular Psychiatry|April 11, 2023
Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulationIrene Perini, Leah M Mayo, Andrea J Capusan, et al.
Science (New York, N.Y.)|February 16, 2008
Neurokinin 1 receptor antagonism as a possible therapy for alcoholismDavid T George, Jodi Gilman, Jacqueline Hersh, et al.
Addiction Biology|April 15, 2020
The future of translational research on alcohol use disorderLara A Ray, Erica N Grodin, Lorenzo Leggio, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2014
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmissionGiordano de Guglielmo, Miriam Melis, Maria Antonietta De Luca, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2015
PPARc activation attenuates opioid consumption and modulates mesolimbic dopamine transmissionGiordano de Guglielmo, Miriam Melis, Maria Antonietta De Luca, et al.
Alcoholism, Clinical and Experimental Research|April 19, 2018
Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol UseJi Soo Lee, Jill L Sorcher, Allison D Rosen, et al.
Molecular Psychiatry|August 19, 2018
Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and miceLeah M Mayo, Anna Asratian, Johan Lindé, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 17, 2015
Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G PolymorphismJ Elliott Robinson, Eyal Vardy, Jeffrey F DiBerto, et al.
Gene|February 2, 2016
mRNA GPR162 changes are associated with decreased food intake in rat, and its human genetic variants with impairments in glucose homeostasis in two Swedish cohortsVanni Caruso, Smitha Sreedharan, Valeria P Carlini, et al.
Biological Psychiatry|February 20, 2013
Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring ratsJesse R Schank, Jenica D Tapocik, Estelle Barbier, et al.
Pageof 32

Showing results (291-300 of 313) with videos related to

Sort By:
Pageof 32
Molecular Psychiatry|April 11, 2023
Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulationIrene Perini, Leah M Mayo, Andrea J Capusan, et al.
Science (New York, N.Y.)|February 16, 2008
Neurokinin 1 receptor antagonism as a possible therapy for alcoholismDavid T George, Jodi Gilman, Jacqueline Hersh, et al.
Addiction Biology|April 15, 2020
The future of translational research on alcohol use disorderLara A Ray, Erica N Grodin, Lorenzo Leggio, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2014
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmissionGiordano de Guglielmo, Miriam Melis, Maria Antonietta De Luca, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2015
PPARc activation attenuates opioid consumption and modulates mesolimbic dopamine transmissionGiordano de Guglielmo, Miriam Melis, Maria Antonietta De Luca, et al.
Alcoholism, Clinical and Experimental Research|April 19, 2018
Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol UseJi Soo Lee, Jill L Sorcher, Allison D Rosen, et al.
Molecular Psychiatry|August 19, 2018
Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and miceLeah M Mayo, Anna Asratian, Johan Lindé, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 17, 2015
Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G PolymorphismJ Elliott Robinson, Eyal Vardy, Jeffrey F DiBerto, et al.
Gene|February 2, 2016
mRNA GPR162 changes are associated with decreased food intake in rat, and its human genetic variants with impairments in glucose homeostasis in two Swedish cohortsVanni Caruso, Smitha Sreedharan, Valeria P Carlini, et al.
Biological Psychiatry|February 20, 2013
Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring ratsJesse R Schank, Jenica D Tapocik, Estelle Barbier, et al.
Pageof 32